Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Authors › Posts by Matthew Perrone

Matthew Perrone

Read the latest stories and analysis from Matthew Perrone.

Business

FDA weighs cancer risk of fibroid removal devices

Matthew Perrone · July 11, 2014 10:44 pm
Business

Who pays your doc? Coming soon to a site near you

Matthew Perrone · July 9, 2014 6:18 pm
Business

Express Scripts cuts payments for customized drugs

Matthew Perrone · July 3, 2014 2:25 pm
In this Thursday, June 19, 2014 photo, technical assistant Eliska Didyk transfers human fecal matter solution into a bottle in an OpenBiome laboratory, in Medford, Mass. With many patients no longer responding to potent antibiotics, stool has emerged as a surprisingly effective treatment for hard-to-treat gut infections. Fecal transplants pose a unique challenge for the Food and Drug Administration, which has been trying to confirm the safety of the new therapy by regulating it as an experimental drug. (AP Photo/Steven Senne) Business

FDA grapples with oversight of fecal transplants

Matthew Perrone · June 26, 2014 5:20 pm
Business

FDA warns of allergic reactions with acne products

Matthew Perrone · June 25, 2014 6:37 pm
Business

FDA outlines policy for overseeing nanotechnology

Matthew Perrone · June 24, 2014 8:05 pm
Business

FDA approves Cubist antibiotic for skin infections

Matthew Perrone · June 20, 2014 10:31 pm
Business

Feds seek ways to expand use of addiction drug

Matthew Perrone · June 18, 2014 8:21 pm
FILE - In this May 30, 2014 file photo, Food and Drug Administration (FDA) Commissioner Dr. Margaret Hamburg answers questions during an interview at The Associated Press in Washington. While Hamburg acknowledged that opioids are overprescribed, she again emphasized the importance of keeping the drugs accessible to Americans with chronic pain _ a group estimated at about 100 million, or about 40 percent of all U.S. adults (AP Photo/J. David Ake, File) Business

Federal views diverge on proper use of painkillers

Matthew Perrone · June 10, 2014 5:07 pm
FILE - In this April 2, 2014 file photo, Teresa Lynch, owner of Dynamic Tanning in DeKalb, Ill., wipes down a tanning bed. Tanning beds and sun lamps will carry new warnings that they should not be used by anyone under age 18, under a government action Thursday, May 29, 2014, aimed at reducing rising rates of skin cancer linked to the radiation-emitting devices. (AP Photo/Daily Chronicle, Monica Maschak, File)  MANDATORY CREDIT Business

Government warns against indoor tanning for minors

Matthew Perrone · May 29, 2014 9:40 pm
Business

FDA lowers Lunesta dose due to next-day drowsiness

Matthew Perrone · May 15, 2014 5:57 pm
Business

Senators warn of carcinogen risk with e-cigarettes

Matthew Perrone · May 8, 2014 7:38 pm
Advertisement
  • ‹Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 13
  • ›Next page
Page 3 of 13
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement